info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142595 |
| CAS No | NA |
| Mol.F. | C16H26N2O4 |
| Mol.Wt. | 310.39 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142596 |
| CAS No | NA |
| Mol.F. | C13H20N2O4 |
| Mol.Wt. | 268.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142597 |
| CAS No | NA |
| Mol.F. | C19H29N3O5 |
| Mol.Wt. | 379.46 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142598 |
| CAS No | NA |
| Mol.F. | C11H15N3O4 |
| Mol.Wt. | 253.26 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142599 |
| CAS No | NA |
| Mol.F. | C12H13N3O5 |
| Mol.Wt. | 279.25 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142600 |
| CAS No | NA |
| Mol.F. | C18H27N3O3 |
| Mol.Wt. | 333.43 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142601 |
| CAS No | NA |
| Mol.F. | C19H31N3O4 |
| Mol.Wt. | 365.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142602 |
| CAS No | NA |
| Mol.F. | C22H36N2O9 |
| Mol.Wt. | 472.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142603 |
| CAS No | NA |
| Mol.F. | C8H11N3O2 |
| Mol.Wt. | 181.20 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142604 |
| CAS No | NA |
| Mol.F. | C15H19N4O |
| Mol.Wt. | 271.34 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142605 |
| CAS No | NA |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.21 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142606 |
| CAS No | NA |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.20 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142607 |
| CAS No | 151512-14-0 |
| Mol.F. | C6H12N4O3 |
| Mol.Wt. | 188.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142608 |
| CAS No | NA |
| Mol.F. | C32H45N5O4 |
| Mol.Wt. | 563.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142609 |
| CAS No | NA |
| Mol.F. | C24H26N4O4 |
| Mol.Wt. | 434.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142610 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
